GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kindred Healthcare Inc (NYSE:KND) » Definitions » Intrinsic Value: Projected FCF

Kindred Healthcare (Kindred Healthcare) Intrinsic Value: Projected FCF : $0.00 (As of May. 05, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Kindred Healthcare Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-05-05), Kindred Healthcare's Intrinsic Value: Projected FCF is $0.00. The stock price of Kindred Healthcare is $9.00. Therefore, Kindred Healthcare's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Kindred Healthcare's Intrinsic Value: Projected FCF or its related term are showing as below:

KND's Price-to-Projected-FCF is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.275
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Kindred Healthcare Intrinsic Value: Projected FCF Historical Data

The historical data trend for Kindred Healthcare's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kindred Healthcare Intrinsic Value: Projected FCF Chart

Kindred Healthcare Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.49 23.71 17.45 11.46 5.93

Kindred Healthcare Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.14 7.43 6.61 5.93 3.73

Competitive Comparison of Kindred Healthcare's Intrinsic Value: Projected FCF

For the Medical Care Facilities subindustry, Kindred Healthcare's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kindred Healthcare's Price-to-Projected-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Kindred Healthcare's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Kindred Healthcare's Price-to-Projected-FCF falls into.



Kindred Healthcare Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Kindred Healthcare's Free Cash Flow(6 year avg) = $18.30.

Kindred Healthcare's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Mar18)*0.8)/Shares Outstanding (Diluted Average)
=(9.5203515959648*18.3048+114.567*0.8)/88.526
=3.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kindred Healthcare  (NYSE:KND) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Kindred Healthcare's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=9.00/3.0038828354813
=3.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kindred Healthcare Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Kindred Healthcare's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Kindred Healthcare (Kindred Healthcare) Business Description

Traded in Other Exchanges
N/A
Address
Kindred Healthcare Inc is a healthcare-services company in the United States that operates in four divisions: hospitals, Kindred at Home, Kindred Rehabilitation Services, and nursing centers. The hospital division provides long-term acute-care services through a network of transitional-care hospitals. The Kindred at Home division provides home health and hospice care for patients in their homes, nursing centers, and other residential settings. This segment contributes the majority of the firm's total revenue. The Rehabilitation Services division provides physical and occupational therapy to residents of nursing centers, hospitals, outpatient clinics, and assisted living facilities. Kindred's nursing center division operates nursing centers and assisted-care facilities.
Executives
Heyward R Donigan director 452 DISCOVERY ROAD, VIRGINIA BEACH VA 23451
Phyllis R Yale director
Paul J Diaz director 680 SOUTH FOURTH STREET, LOUISVILLE KY 40202
Joel Ackerman director COVENTRY HEALTH CARE, INC., 6705 ROCKLEDGE DR SUITE 900, BETHESDA MD 20817
Richard Goodman director PEPSICO, INC., 700 ANDERSON HILL ROAD, PURCHASE NY 10577
Christopher T Hjelm director C/O THE KROGER CO., 1014 VINE ST., CINCINNATI OH 45202
Stephen D Farber officer: EVP & Chief Financial Officer 680 SOUTH FOURTH STREET, LOUISVILLE KY 40202
Jonathan David Blum director C/O YUM BRANDS INC, 1441 GARDINER LANE, LOUISVILLE KY 40213
Lynn T Simon director 4000 MERIDIAN BOULEVARD, FRANKLIN TN 37067
Fred J Kleisner director C/O MORGANS HOTEL GROUP CO., 475 TENTH AVENUE, NEW YORK NY 10018
Sharad Mansukani director C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Thomas P Cooper director PO BOX 3335, SANTA FE CA 92067
John H Short director 7733 FORSYTH BLVD.,, SUITE 2300, ST. LOUIS MO 63105
Edward L Kuntz director, other: Chairman of the Board
Richard A Lechleiter officer: Executive VP and CFO PO BOX 32890, LOUISVILLE KY 40232-2890